Dissemination of extended-spectrum β-lactamases and quinolone resistance genes among clinical isolates of uropathogenic escherichia coli in children

Jundishapur Journal of Microbiology

Volumn 8, Issue 7, 2015, Pages

  Sedighi, Iraj ^a   Arabestani, Mohammad Reza ^a,b   Rahimbakhsh, Ali ^c   Karimitabar, Zahra ^a   Alikhan, Mohammad Yousef ^a,b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Antibiotic Resistance; Escherichia coli; Quinolones

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE CTX M; CEFPODOXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHILD; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; HUMAN; NONHUMAN; QNRA GENE; QNRB GENE; QNRS GENE; QUINOLONE RESISTANCE GENE; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84937887009     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.19184v2     Document Type: Article

References (31)

1. Murray PR, Baron EJ, Jorgensen J. H., Landry ML, Michael A, Pfaller MA. Manual of Clinical Microbiology. 9th ed: American Society for Microbiology 2007.
2. Piatti G, Mannini A, Balistreri M, Schito AM. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol. 2008; 46(2):480–7.
3. White B. Diagnosis and treatment of urinary tract infections in children. Am Fam Physician. 2011; 83(4):409–15.
4. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003; 47(7):2242–8.
5. Wang M, Sahm DF, Jacoby GA, Hooper DC. Emerging plasmidmediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother. 2004; 48(4):1295–9.
6. Jeong JY, Yoon HJ, Kim ES, Lee Y, Choi SH, Kim NJ, et al. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother. 2005; 49(6):2522–4.
7. Schleiss MR. Principles of Antibacterial Therapy. In: Kliegman RM editor. Nelson text book of pediatrics. 19th ed. Philadelphia: Elsevier; 2011.
8. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998; 351(9105):797–9.
9. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006; 6(10):629–40.
10. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009; 22(4):664–89.
11. Khodursky AB, Zechiedrich EL, Cozzarelli NR. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci U S A. 1995; 92(25):11801–5.
12. Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005; 49(1):118–25.
13. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4):493–6.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement.Wayne, PA: CLSI 2007.
15. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 2009, 53(2):639–45.
16. Chroma M, Kolar M. Genetic methods for detection of antibiotic resistance: focus on extended-spectrum beta-lactamases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010; 154(4):289–96.
17. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007; 60(2):394–7.
18. Datta P, Thakur A, Mishra B, Gupta V. Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India. Jpn J Infect Dis. 2004; 57(4):146–9.
19. Daoud Z, Hakime N. [Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon]. Rev Esp Quimioter. 2003; 16(2):233–8.
20. Shayanfar N, Rezaei M, Ahmadi M, Ehsanipour F. Evaluation of extended spectrum beta-lactamase (ESBL) positive strains of Klebsiellsiella pneumoniae and Escherichia coli in bacterial cultures. Iran J Pathol. 2010; 5:34–9.
21. Franiczek R, Dolna I, Krzyzanowska B, Szufnarowski K, Kowalska-Krochmal B. Conjugative transfer of multiresistance plasmids from ESBL-positive Escherichia coli and Klebsiella spp. clinical isolates to Escherichia coli strain K12 C600. Adv Clin Exp Med. 2007; 16(2):239–47.
22. Bali E, Acik, L. , Sultan, N. Phenotypic and molecular characterization of SHV, TEM and CTX-M and extended spectrum beta -lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res. 2010; 4(8):650–4.
23. Sorlozano A, Gutierrez J, Fernandez F, Soto MJ, Piedrola G. A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain). Ann Microbiol. 2004; 54(2):99–104.
24. Park Y, Kang HK, Bae IK, Kim J, Kim JS, Uh Y, et al. Prevalence of the extended-spectrum beta-lactamase and qnr genes in clinical isolates of Escherichia coli. Korean J Lab Med. 2009; 29(3):218–23.
25. Hussain M, Hasan F, Shah AA, Hameed A, Jung M, Rayamajhi N, et al. Prevalence of class A and AmpC beta-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn J Infect Dis. 2011; 64(3):249–52.
26. Yazdi M, Nazemi A, Miri Nargesi MS, Khatami Nejad MR. Prevallence of SHV/CTX-M/TEM beta lactamase resistance genes in Escherichia coli isolated from UTI in Tehran city. Iran J Pathol. 2010; 4:48–54.
27. Rodriguez-Villalobos H, Malaviolle V, Frankard J, de Mendonca R, Nonhoff C, Struelens MJ. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother. 2006; 57(4):771–4.
28. Bonnedahl J, Drobni M, Gauthier-Clerc M, Hernandez J, Granholm S, Kayser Y, et al. Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS One. 2009; 4(6):e5958.
29. Padmini B, Appalaraju SB. Extended spectrum beta lactamases in urinary isolates of Escherichia coli and Klebsiella pneumonia - prevalence and susceptibility pattern in a tertiary care hospital. Ind J Med Microbiol. 2004; 22(3):172–4.
30. Oktem IM, Gulay Z, Bicmen M, Gur D, Hitit Project Study Group . qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey. Jpn J Infect Dis. 2008; 61(1):13–7.
31. Bouchakour M, Zerouali K, Gros Claude JD, Amarouch H, El Mdaghri N, Courvalin P, et al. Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing enterobacteriaceae in Morocco. J Infect Dev Ctries. 2010; 4(12):779–803.